Geron Corp. (GERN)
1.23
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 11:22
Geron EPS Diluted (Quarterly): -0.0276 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cassava Sciences, Inc. | -0.2237 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| GT Biopharma, Inc. | -0.8268 |
| Ultragenyx Pharmaceutical, Inc. | -1.808 |
| Arcellx, Inc. | -0.9858 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.43M |
| Revenue (Quarterly) | 47.23M |
| Total Expenses (Quarterly) | 65.66M |
| Enterprise Value | 654.02M |
| Gross Profit Margin (Quarterly) | 97.13% |
| Profit Margin (Quarterly) | -39.02% |
| Earnings Yield | -9.77% |
| Normalized Earnings Yield | -9.626 |